Education
About Us
Working with TipRanks
Follow Us
EuroEyes International Eye Clinic Limited (HK:1846)
:1846
1846 Stock Chart & Stats
HK$3.00
-HK$0.02(-0.53%)
At close: 4:00 PM EST
HK$3.00
-HK$0.02(-0.53%)
Day’s Range― - ―
52-Week RangeHK$2.52 - HK$3.59
Previous CloseN/A
Volume15.00K
Average Volume (3M)156.72K
Market Cap
HK$911.35M
Enterprise ValueHK$565.78M
Total Cash (Recent Filing)HK$769.46M
Total Debt (Recent Filing)HK$345.45M
Price to Earnings (P/E)12.1
Beta0.24
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)0.12
Shares Outstanding320,706,000
10 Day Avg. Volume164,000
30 Day Avg. Volume156,720
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)1.19
Price to Sales (P/S)1.82
P/FCF Ratio11.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialized Multi-country Clinical PlatformEuroEyes' focused clinical model—laser, cataract and corrective services delivered via experienced clinicians and advanced tech—creates durable demand and high service specialization. Multi-country presence diversifies patient flow and referral networks, supporting stable long-term revenue generation and scale benefits.
Conservative Balance Sheet And Low LeverageHigh equity ratio and low debt provide financial flexibility for capex, site expansion or downturns without straining interest service. This capital structure reduces insolvency risk, supports investment in equipment/technology, and underpins durable operational resilience and strategic optionality.
Scale With Multi-year Revenue Growth And Solid Operating MarginsSustained top-line expansion to meaningful scale improves fixed-cost absorption and strengthens bargaining power for supplies and staffing. Continued healthy EBIT/EBITDA margins indicate operational control; combined with scale, this supports reinvestment capacity and long-term competitive positioning.
Bears Say
Eroding Gross And Net Profit MarginsMaterial margin compression signals rising direct costs or pricing pressure and, if persistent, will reduce cash available for reinvestment and growth. Shrinking margins can impair ability to fund technology upgrades, marketing, or expansion, weakening long-term return on invested capital.
Absent 2024 Operating And Free Cash Flow ReportingMissing OCF/FCF data creates uncertainty about cash conversion of reported profits. Without clear cash generation, the company may face constraints funding capex, servicing obligations, or returning capital, increasing execution risk even if accounting earnings appear solid.
Recent Revenue And EPS ContractionNegative recent revenue growth and a steep EPS decline indicate near-term demand softness or margin shocks. Continued weakness raises the risk that prior growth momentum is stalling, complicating recovery plans and potentially requiring price or cost actions that could impair long-term profitability.
EuroEyes International Eye Clinic Limited News
1846 FAQ
What was EuroEyes International Eye Clinic Limited’s price range in the past 12 months?
EuroEyes International Eye Clinic Limited lowest stock price was HK$2.52 and its highest was HK$3.59 in the past 12 months.
What is EuroEyes International Eye Clinic Limited’s market cap?
EuroEyes International Eye Clinic Limited’s market cap is HK$911.35M.
When is EuroEyes International Eye Clinic Limited’s upcoming earnings report date?
EuroEyes International Eye Clinic Limited’s upcoming earnings report date is Apr 01, 2026 which is in 36 days.
How were EuroEyes International Eye Clinic Limited’s earnings last quarter?
EuroEyes International Eye Clinic Limited released its earnings results on Aug 28, 2025. The company reported HK$0.121 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.121.
Is EuroEyes International Eye Clinic Limited overvalued?
According to Wall Street analysts EuroEyes International Eye Clinic Limited’s price is currently Overvalued.
Does EuroEyes International Eye Clinic Limited pay dividends?
EuroEyes International Eye Clinic Limited pays a Quarterly dividend of HK$0.032 which represents an annual dividend yield of 1.99%. See more information on EuroEyes International Eye Clinic Limited dividends here
What is EuroEyes International Eye Clinic Limited’s EPS estimate?
EuroEyes International Eye Clinic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EuroEyes International Eye Clinic Limited have?
EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding.
What happened to EuroEyes International Eye Clinic Limited’s price movement after its last earnings report?
EuroEyes International Eye Clinic Limited reported an EPS of HK$0.121 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.01%.
Which hedge fund is a major shareholder of EuroEyes International Eye Clinic Limited?
Currently, no hedge funds are holding shares in HK:1846
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EuroEyes International Eye Clinic Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.87%
12-Months-Change
Fundamentals
Return on Equity
6.35%
Trailing 12-Months
Asset Growth
5.90%
Trailing 12-Months
Company Description
EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. Its correction services are used for the treatment of myopia, high myopia, presbyopia, and cataract. The company serves mid-to-high income level customers, who primarily seek surgery to treat their myopia; and above 45 years of age, who primarily seek surgery to treat their presbyopia or cataract. It operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in the trading of eye clinic equipment and lenses; and ophthalmic equipment renting and spaces operating activities. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.
Technical Analysis
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hospital Corporation of China Ltd
―
Arrail Group Ltd.
―
Options Prices
Currently, No data available
---